ESR2 and glioblastoma: Furthermore, a selective ERβ agonist, erteberel, sensitized GBM cells to several DNA-damaging drugs such as cisplatin, lomustine, and TMZ in vitro, significantly reducing the growth of orthotopically implanted GL26 GBM cells in mice [64].